GWW
74
2
UPS
64
4
DUK
57
2
ALL
45
-6
FMC
40
6
FDX
46
3
PWR
74
2
KSS
46
12
EXPD
53
8
JNJ
47
3
HAL
62
2
CCI
33
2
LH
48
5
PFE
26
3
KMX
70
6
HPQ
60
-3
MMM
37
5
V
76
10
PDCO
46
8
SIG
55
5
GWW
74
2
UPS
64
4
DUK
57
2
ALL
45
-6
FMC
40
6
FDX
46
3
PWR
74
2
KSS
46
12
EXPD
53
8
JNJ
47
3
HAL
62
2
CCI
33
2
LH
48
5
PFE
26
3
KMX
70
6
HPQ
60
-3
MMM
37
5
V
76
10
PDCO
46
8
SIG
55
5
Financhill
Back

Alnylam Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
28

ALNY
Alnylam Pharmaceuticals

Last Price:
253.02
Seasonality Move:
7.55%
Buy
64

BMRN
Biomarin Pharmaceutical

Last Price:
64.87
Seasonality Move:
8.34%
Sell
28
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $250.98. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $65.09. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $250.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $65.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.08 Sell
Relative Strength Index (14 RSI): 42.53 Sell
Chaikin Money Flow: -128014 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (248.66 - 286.24) Sell
Bollinger Bands (100): (248.76 - 281.72) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.76 Sell
Relative Strength Index (14 RSI): 43.34 Sell
Chaikin Money Flow: 264765 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.82 - 68.94) Sell
Bollinger Bands (100): (67.7 - 87.1) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 243.93 Buy
20-day SMA: 261.47 Sell
50-day SMA: 272.2 Sell
200-day SMA: 212.03 Buy
8-day EMA: 248.95 Buy
20-day EMA: 258.56 Sell
50-day EMA: 264.73 Sell
200-day EMA: 231.23 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.54 Buy
20-day SMA: 65.43 Sell
50-day SMA: 68.16 Sell
200-day SMA: 80.94 Sell
8-day EMA: 64.16 Buy
20-day EMA: 65.52 Sell
50-day EMA: 69.56 Sell
200-day EMA: 79.24 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):